Gene Variant Tied to Lower Non-HDL-Cholesterol Levels, CAD Risk

The ASGR1 mutation's benefit/risk ratio exceeded what would be predicted from its non-HDL-C effect, suggesting its protection "goes beyond the lowering of serum cholesterol," according to researchers.